微RNA技术的新兴前沿:创新驱动精密医学
Shanshan Guo1, Yiming Wang2, Hongxin Zhao3
1College o0f Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China; State Key Laboratory of Green Biomanufacturing, Department of Chemical Engineering, Tsinghua University, Beijing, 100084, China; Key Laboratory of Industrial Biocatalysis, Ministry of Education, Department of Chemical Engineering, Tsinghua University, Beijing, 100084, China.
Biomaterials
|September 20, 2025
概括
微RNAs (miRNAs) 是具有诊断和治疗潜力的关键基因调节剂. 检测,输送和人工智能的进步正在克服各种疾病中精准医学应用的挑战.
科学领域:
- 生物化学和分子生物学
- 生物技术是生物技术.
- 遗传学 遗传学 是一个
背景情况:
- 微RNA (miRNA) 对基因调节至关重要,对疾病诊断,治疗和精准医学具有前景.
- 目前面临的挑战包括检测的低灵敏度/特异性,低效的传递系统和缺乏标准化.
- 解决这些局限性对于将miRNA潜力转化为临床实践至关重要.
研究的目的:
- 审查用于诊断和治疗的miRNA技术的最新进展.
- 突出人工智能 (AI) 对基于miRNA的药物设计和目标预测的影响.
- 讨论miRNAs的多种疾病潜力,并提出未来的研究方向.
主要方法:
- 对高灵敏度核酸放大平台的审查.
- 基于纳米技术的生物传感器用于miRNA检测的分析.
- 检查人工智能驱动的方法用于miRNA目标预测和药物开发.
主要成果:
- 新兴技术在改善miRNA检测灵敏度和特异性方面显示出前景.
- 人工智能显著提高了基于miRNA的药物设计和目标识别.
- miRNAs在癌症,心血管和神经退行性疾病中表现出广泛的潜力.
结论:
- 先进的miRNA技术,包括AI和纳米生物传感器,已经准备好克服当前的局限性.
- 精确传递系统和多omics集成是未来临床翻译的关键.
- 跨学科的合作对于推动miRNA应用从研究到临床实践至关重要.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
987
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
987
01:22MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
01:22MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
02:15Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
02:30siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K